Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial-Reference-Cited by-同舟云学术

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial

Published:2023-12 Issue: Volume:137 Page:28-39
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Hejazi Nima S.^ORCID,Shen Xiaoying,Carpp Lindsay N.^ORCID,Benkeser David^ORCID,Follmann Dean,Janes Holly E.,Baden Lindsey R.,El Sahly Hana M.^ORCID,Deng Weiping,Zhou Honghong,Leav Brett,Montefiori David C.,Gilbert Peter B.

Funder

U.S. Department of Health and Human Services

National Institute of Allergy and Infectious Diseases

Biomedical Advanced Research and Development Authority

Administration for Strategic Preparedness and Response

National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials;Hejazi;Biometrics,2021

2. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial;Gilbert;Science,2022

3. Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine;Benkeser;npj Vaccines,2023

4. Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial;Fong;Nat Commun,2023

5. Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial;Fong;Nat Microbiol,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial;Nature Communications;2024-09-11

2. Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases;Nature Communications;2024-08-29

3. Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial;Vaccine;2024-04

4. Long-term safety and efficacy of COVE study open-label and booster phases;2024-03-14

5. Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial;2023-10-15